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Abstract
Background: Diabetes is an important health burden in Indonesia. However, diabetes management and treatment
remain poor, with most people with diabetes in Indonesia not achieving the recommended blood glucose levels.
Peer education may have particular potential in low-income settings in complementing diabetes care without
being a large additional strain on the health system.
Methods/design: This cluster randomized controlled trial aims to identify the effect of the implementation of peer
education for patients with type 2 diabetes on diabetes-related outcomes in Aceh, Indonesia, which will
complement the diabetes treatment provided at primary-care health posts (puskesmas). Altogether, 29 puskesmas
were recruited in Banda Aceh and Aceh Besar, each of which was randomly assigned to either the control or the
intervention group. Then, 534 people with diabetes were identified and recruited through their respective
puskesmas. The intervention consists of up to two peer education groups per puskesmas, which are led by
previously trained people with diabetes. Peer education sessions are held every month for 18 months, with follow-
up data being collected 9 and 18 months after the first peer education session.
The main objective is to improve diabetes management and the health behavior of participants receiving peer
education to reduce their average blood glucose levels as measured by glycated hemoglobin (HbA1c) levels.
Secondary outcomes are the effects of peer education on lipid levels, waist circumference, blood pressure, quality
of life, treatment adherence, diabetes knowledge, physical activity, and dietary diversity. Data sources for the
measurement of outcomes include patient and health facility surveys and biomarker measurements. An economic
evaluation will be conducted to assess the cost-effectiveness of the intervention.
Discussion: This trial will contribute to the evidence on the effectiveness and cost-effectiveness of peer education
in improving diabetes management in a low-income setting in Indonesia and in other comparable contexts.
Trial registration: ISRCTN registry, ISRCTN68253014. Registered on 18 February 2019.
Keywords: Peer education, Patient-led education, Diabetes, Cluster randomized controlled trial, Non-communicable
diseases, Indonesia, Cost-effectiveness
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Background
Public health systems in low- and middle-income coun-
tries are overburdened with the demands of delivering
care to those with communicable and non-communicable
diseases. People with the latter in particular often require
long-term monitoring and support to achieve good health
[1]. For diabetes, inadequate care or no access to care can
lead to high rates of uncontrolled diabetes and complica-
tions. It is unclear, however, how better care can be
provided in an environment with few resources, as is the
case in low- and middle-income countries.
In Indonesia, diabetes has become one of the main
contributors to the burden of disease, surpassing many
communicable diseases, especially among adults [2].
However, diabetes treatment at the main public pri-
mary-care facilities, puskesmas, remains poor, which is
partly due to the limited knowledge of health-care pro-
fessionals about diabetes [2, 3]. Consequently, recent
studies on diabetes in Indonesia indicate poor levels of
control, with around 70% of patients having glycated
hemoglobin (HbA1c) levels above 7% [4].
A potential way to complement the diabetes care avail-
able in Indonesia is the use of peer education, in which
highly motivated and trained diabetes patients educate
and support other patients with diabetes to manage the
disease in daily life in a culturally appropriate way. Due
to the need for patients to deal with their diabetes every
day, and the potential of lifestyle changes and preventa-
tive behavior to prevent major diabetes complications,
empowering patients by increasing their knowledge of
diabetes care could theoretically yield positive results.
Peer education focuses and relies on people with
diabetes, rather than medical professionals, to improve
diabetes care. Therefore, it may be less resource inten-
sive than traditional approaches and particularly attract-
ive in environments where access to and the quality of
diabetes health care are very limited [5].
Several randomized controlled trials have been con-
ducted in recent years to test the efficacy of peer education
in improving diabetes outcomes in high- and in some low-
and middle-income countries. Two systematic reviews
have indicated that peer education overall can lead to
statistically significant reductions in HbA1c levels [5, 6]. It
appears that it is especially effective for some sub-groups
of diabetes patients, such as those with relatively uncon-
trolled diabetes [5] and minorities [6]. Because most of the
trials reviewed took place in high-income countries, these
results may not be directly applicable to relatively poorer
countries. The two studies that evaluated the effects of peer
education in a middle-income country (China and
Argentina), took place in an urban environment (La Plata,
Argentina [7] and Hong Kong [8]).
Hence, there is a lack of evidence on the causal effect
of peer education in low- and middle-income countries,
in particular on its adaptability to non-urban environ-
ments where diabetes care mainly happens at the pri-
mary-care level.
Our study results may, therefore, play an important
part in advancing the knowledge base on the treatment
of diabetes in low- and middle-income countries. In
particular, it may provide evidence of its effectiveness in
a setting that consists of both urban and relatively re-
mote rural areas, and where traditional beliefs around
diabetes and the use of alternative medicines are still
relatively common [4].
Moreover, our study will look at the effectiveness of
peer education over a relatively long time of 18 months.
It further aims not only to look at HbA1c, but also at
changes in lipid levels as well as blood pressure and
waist circumference, given their role as risk factors for
diabetes-related complications. Because peer education
relies on the ability of peer educators to train their peers
and the peers’ ability to use this information to change
their behavior, we will also assess if the personal charac-
teristics of study participants can mediate the success of
the intervention. In particular, we want to investigate
the role of time and risk preferences, which may mediate
the ability of participant to prioritize behavior change
today to prevent diabetes complications in the future.
Finally, our study will provide estimates of the cost-ef-
fectiveness of peer education in a low-income context of
a developing country. This will add further evidence
about the viability of peer education in health systems of
low- and middle-income countries in terms of its finan-
cial costs and effectiveness.
Methods/design
Study setting
In Indonesia, most people with diabetes receive their regu-
lar diabetes treatment at the primary-care level at public
health posts called puskesmas. These are government-
mandated primary-care providers and the first point of
contact for people seeking care in the public health system
in Indonesia. Each puskesmas normally serves one sub-
district, which has a population of 30,000 to 50,000. The
main role of puskesmas is the delivery of primary out-
patient care, but they are also used to promote and realize
public health measures such as immunization, nutrition
education and health information campaigns. About one-
third of puskesmas in Indonesia provide basic inpatient
care for emergency obstetric and neonatal care. Out-
patient care efforts have mainly focused on communicable
diseases, so that many puskesmas, especially in rural areas,
provide a low quality of diabetes services [2]. This is
characterized by a limited capacity to detect diabetes via
diagnostic tests, and to treat and manage diabetes and its
complications. Diabetes care is mainly limited to the use
of medication to control the disease, and mostly
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disregards patient education on topics such as diet or
exercise [2, 3]. The diabetes burden in Aceh is mostly un-
known, but judging from national data, substantial [2].
This study is taking place at puskesmas in the districts
Banda Aceh and Aceh Besar in the north of Sumatra, with
Banda Aceh consisting of mostly urban areas and Aceh
Besar of rural areas.
Study design
The study is a cluster randomized controlled trial with a
parallel group design, with the clusters consisting of
puskesmas from Banda Aceh and Aceh Besar Regency.1 Peer
education groups were randomly established in 50% of
puskesmas after they joined the study and baseline data col-
lection had been terminated. This study design allows us to
establish two groups of participants (treatment and control
group) so that we can causally identify the effect of the peer
education on the primary and secondary outcomes. Blinding
was possible at baseline, which preceded the allocation of
clusters into treatment and control groups. However, after
the randomization and allocation, the blinding of the treat-
ment allocation of participants, project managers, and inves-
tigators is no longer possible. For the duration of the study,
the control group will not receive any intervention beyond
being informed about their blood test results. The Standard
Protocol Items: Recommendations for Interventional Trials
(SPIRIT) checklist is provided as an Additional file 1.
Intervention: peer education
Peer support has been defined as “support from a person
who possesses experiential knowledge of a specific
behavior or stressor and similar characteristics as the
target population” [9]. It has been shown to help reduce
or prevent problematic health behaviors and alleviate
vascular disease, HIV, and Parkinson’s disease among
others [5]. The appeal of peer support is its ability to
create nonhierarchical reciprocal relationships through
the sharing of similar life experiences between the peer
educator and the peers. Additionally, because peer edu-
cation relies on non-professionals to improve the health
outcomes of patients, it may be significantly less re-
source intensive than trying to achieve the same effects
with professional health workers.
The intervention was designed in cooperation with the
local expert team as well as experts experienced with the
implementation of peer education in a low-income con-
text in Mali [10]. Furthermore, qualitative interviews and
focus group discussions with nurses working with diabetes
patients at puskesmas informed the intervention design, in
particular regarding practicable ways to train peer
educators and to provide them with the means to transfer
their knowledge successfully to their peer groups.
Training of peer educators
Selected peer educators will receive training before and
after the start of the implementation. A 2-day intensive
training session by local physicians on diabetes and
nutrition was carried out at the beginning of April 2019
before the start of the peer education sessions. It pro-
vided general information about diabetes as a disease, its
risks, and the ways to treat it. This initial information
session will be followed up by monthly half-day training
sessions for the peer educators until the end of the
study. These training sessions for peer educators will be
led by two specially trained nurses, who, prior to each
training session, will be educated by a member of the re-
search team on the specific topic to be discussed. The
topics and structure of the peer educator training ses-
sions will be guided by the peer leader manual published
by the International Diabetes Federation [11]. The goals
of these additional education sessions [1] are to distrib-
ute the burden of training sessions for peer educators
over a longer period of time [2], to maintain the motiv-
ation and commitment of peer educators over time [3],
and to use feedback from the peer educators after their
peer education sessions to adapt the training to the
needs of the peer educators and their peers.
Use of peer education
Depending on the number of patients recruited per
puskesmas and the number of potential peer educators,
one or two peer educators will be selected per puskes-
mas, to limit the group size to 13 participants. Peer edu-
cation sessions are planned to be held once a month for
18 months. They will be conducted by the peer educator
only, without the presence of a trained nurse or a mem-
ber of the research staff, to avoid any potential changes
in the behavior of the peer educator or the patients. To
preserve some flexibility in how peer educators conduct
the peer education sessions and react to the needs of the
group, we will refrain from closely monitoring each
session. Rather, we will use feedback from the peer
educators about the sessions to determine if they are
successful in discussing the planned topics.
Research questions
The specific research questions are:
1. Will HbA1c levels decrease in patients who take
part in peer education groups and if so, by how
much?
2. What effect will peer education have on lipid levels,
waist circumference, blood pressure, and quality of
life?
1A regency is an administrative unit in Indonesia comparable to
municipalities, just below the level of provinces. Like cities (e.g., Banda
Aceh), regencies have their own local governments and parliaments.
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3. What effect will peer education have on health and
self-care behavior of participants in the intervention
group?
4. Is the intervention cost-effectiveness?
5. What are important mediators for the effectiveness
of peer education?
Outcome measures
The primary outcome is the change in HbA1c levels
from baseline to the final assessment. HbA1c will be col-
lected at baseline, midline and the final assessment using
point-of-care testing devices allowing for the immediate
measurement of HbA1c levels. Secondary outcomes are:
 changes in lipids (total cholesterol, high-density
lipoprotein, and triglycerides) collected using point-
of-care testing devices at baseline, during the trial,
and at the final assessment
 blood pressure
 waist circumference
 diabetes knowledge
 medication adherence (five-item Medication
Adherence Scale, MARS-5 [12])
 diabetes distress (Diabetes Distress Scale 2 [13])
 healthy behaviors, such as smoking status and
number of cigarettes per day, and physical
activity levels (WHO global physical activity
questionnaire [14])
 dietary diversity (dietary diversity questionnaire
published by the Food and Agriculture Organization
of the U.N. [15])
Finally, to assess the cost-effectiveness of the interven-
tion, changes in health-care costs and changes in qual-
ity-adjusted life years (based on EQ-5D-3 L
questionnaire [16]) will be used to calculate the incre-
mental cost-effectiveness ratio of the intervention [16].
Regarding potential mediators, we specifically focus on
the behavioral characteristics of the participants. In
particular, we measure risk and time preferences as well
as trust in other people using unincentivised questions.
We also use the Collective Self-Esteem Scale, which
measures the ability of participants to function in and
identify with social groups [17], and the 13-item Self-
Control Scale [18].
Study duration
A qualitative study to inform the intervention was car-
ried out in May and June 2018. As shown in the SPIRIT
figure (Fig. 1), recruitment occurred in February and
March 2019. Baseline data were collected in April 2019,
including primary and secondary outcome variables, for
all participating patients. The intensive training sessions
Fig. 1 Schedule of enrolment, intervention, and assessments. HbA1c glycated hemoglobin
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of the selected peer educators took place in April 2019
and the peer groups were established in July 2019. The
first follow-up data will be collected in April 2020, in-
cluding primary and secondary outcome variables. This
will be followed by an analysis of the preliminary results.
The final assessment will be conducted in January 2021,
including primary and secondary outcome variables.
This will be followed by an analysis of the results and
the establishment of peer support groups in the control
group if the intervention proves to be effective.
Number of participants and power calculation
The study aimed to include patients from all puskesmas
in Banda Aceh and Aceh Besar.2 Power calculations
indicated that with 680 participants in 34 clusters, an
assumed intra-cluster correlation of HbA1c of 0.37, and
a pooled standard deviation of HbA1c of 1.25, we would
have 80% power to detect a difference of 0.5 in mean
HbA1c using a significance level of p = 0.05 and 90%
power to detect a difference of 0.686 using a significance
level of p = 0.01. We chose a difference of 0.5 in mean
HbA1c, as this has been determined as a clinically mean-
ingful threshold [19]. At the end of the recruitment
phase, we had been able to recruit 534 participants from
31 puskesmas. However, two puskesmas could not be
used as separate cluster units since their low recruitment
numbers prevented the formation of a peer education
group. We decided to assign the participants from these
puskesmas to the geographically closest puskesmas. This
reduced the number of clusters from 31 to 29, which
gives 80% power to detect a difference of 0.57 in mean
HbA1c using a significance level of p = 0.05 and 90%
power to detect a difference of 0.78 using a significance
level of p = 0.01.
Inclusion criteria
While previous studies have shown that there is a real
benefit of peer education for people with very elevated
HbA1c levels, we aim to include any person with type 2
diabetes. There are two main reasons for this decision.
First, many puskesmas in Indonesia are currently not
equipped to test HbA1c levels and would, hence, be un-
able to select patients based on their HbA1c levels. We,
therefore, think that our intervention should reflect the
reality of the current health system and investigate the
suitability of measuring HbA1c levels for later imple-
mentation. Second, we suspect that there is also a bene-
fit of joining peer education for those with better HbA1c
levels, by helping them to prevent a worsening of the
disease over time.
Therefore, we used the following inclusion criteria for
patients in the peer education groups or the control
groups:
 Patients treated in puskesmas for type 2 diabetes in
the intervention area
 Patients who agreed to undergo the whole process
of peer education
 Patients who agreed to carry out all biological and
survey assessments as required by the protocol
 Patients aged 20–79 years
 Patients not enrolled in another research program
The peer educators will need to fulfill the following
requirements:
 Can commit to attending 20 h of training
 Are willing to organize activities with other patients
every month
 Have basic diabetes self-management knowledge and
supportive non-judgmental communication skills
 Willing to lead
 Literate
Exclusion criteria
 Pregnancy
 Being unable to physically attend peer education
sessions
Study procedures
The project has several phases. First, to inform the inter-
vention design, qualitative interviews with nurses and
diabetes patients were carried out. Then, for each
puskesmas, patients with diabetes were recruited into the
peer education program. An interview was carried out in
each facility to receive the facility head’s consent to par-
ticipate, to gather general information and information
specific to diabetes treatment and, if possible, to obtain a
list of diabetes patients. Additionally, health workers in
the puskesmas and in the villages as well as patients who
had already been interviewed were asked to suggest
further people with diabetes who were associated with
the relevant puskesmas.
At baseline, the patients recruited were interviewed by
trained enumerators using a questionnaire. They were
invited to the puskesmas on one predetermined day,
during which the trained enumerators used point-of-care
devices to test their HbA1c and lipid levels. The partici-
pants were informed of their test results. Blood was then
drawn from the arm of participants by health-care pro-
fessionals, which was used for laboratory as well as
2There are 39 puskesmas in total, of which seven were excluded ex
ante for practical reasons as they are located either in the remote
mountainous area or on an island, so that it would not have been
feasible to conduct either the survey or the training of the peer
educators with the given resources.
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point-of-care tests of HbA1c and lipid profiles to
determine the accuracy of the point-of-care test devices
in the study setting under field conditions. In the middle
and final assessments, only point-of-care tests using
venous blood will be carried out.
In choosing potential peer educators, all participants
were asked during the interviews if they would be inter-
ested in serving as a peer educator. Further, health facil-
ity staff were asked during the facility interview to
suggest patients for this role. Out of the participants re-
cruited, we determined potential peer educators based
on three criteria: (1) their willingness to take on this
role, (2) a recommendation from the health facility staff,
and (3) how well they were already controlling their dia-
betes based on the HbA1c level from the baseline data.
Following data collection, the puskesmas were random-
ized. Because recruitment took place before randomization,
the researchers, participants, and facility managers did not
know which facilities would be allocated to the treatment
and control groups. We used covariate-constrained
randomization to ensure the treatment and control arms
were balanced in terms of baseline covariates while main-
taining the randomness of the allocation [20, 21]. The covar-
iates took into account the composition of the group with
regards to size of the group, and the age, sex, education, par-
ticipation in other health programs,3 and diabetes control
(mean HbA1c values) of the members, as well as the
location of the puskesmas (rural or urban). Randomization
was carried out using the statistics program Stata.
Peer education groups were formed at each puskesmas
in the treatment group. Peer educators will receive con-
tinuous training in diabetes management skills and will
be supported in the administrative processes (e.g., room
booking) required to run their peer education group in
their local sub-district.
To ensure that the effect of using peer education can
be observed in comparison to normal patient education
efforts, the control group will not receive any additional
education apart from standard therapy.
As detailed in Fig. 1, 9 months after the first peer edu-
cation session, a first follow-up will assess the imple-
mentation and the effects of peer education. The final
assessment will take place 18 months after the first peer
education session to assess the long-term effects of the
intervention and the experience of participants.
We will then compare the outcomes between treat-
ment and control groups, carry out a cost-effectiveness
analysis, present the results to local health authorities,
and discuss how to implement the program more widely
if it proves to be effective.
Economic evaluation
Costs related to the implementation of peer education
will be collected from the the documented project ex-
penditures. Data on resource use for diabetes treatment
and care, including equipment, drugs, and doctor and
hospital visits, will be collected retrospectively using cost
information from the health insurance provider if pos-
sible, or via the expert opinion of local specialists. These
data will be supplemented with information on partici-
pants’ health-care seeking behavior and utilization, drug
use, and out-of-pocket payments collected through the
surveys.
To estimate cost-effectiveness, the incremental cost-
effectiveness ratio will be calculated from the health-
care system perspective and the societal perspective
taking into account out-of-pocket expenditures and
costs related to participating in peer education. The in-
cremental cost-effectiveness ratio is defined by the
difference in costs between receiving no intervention
plus standard diabetes care and the standard care plus
intervention costs, divided by the difference in their
effect. Here it represents the average incremental cost
for peer education associated with one additional qual-
ity-adjusted life year.
Data management
Data will be collected using tablets and directly entered
into the electronic data entry program Open Data Kit
(ODK collect). Data will be anonymized, and the original
data will be stored separately on an encrypted hard stor-
age device. Any biomarker data will be stored separately
from the participant’s name on an encrypted hard
storage device. The results of the biomarker tests will be
reported back to the participants.
Statistical methods
Random sampling and random assignment of interven-
tion units to the treatment and control groups will allow
us to interpret differences in mean outcomes as causal
effects of the intervention. By comparing outcomes be-
tween participants in the peer education groups com-
pared to study participants in the control group, we will
be able to draw conclusions of the intent-to-treat effect
and the size of the effect.
Because covariate-constrained randomization was used
to balance the baseline characteristics, it is necessary to
account for this design at the analysis stage [21, 22]. We
will use general (generalized) linear mixed models to in-
corporate data structures that are both hierarchical and
longitudinal and adjust for the covariates used during
the covariate-constrained randomization [21, 22]. Stand-
ard errors will be clustered at the intervention unit level
(puskesmas).
3Namely, either the Prolanis or the Posbindu program, which are two
puskesmas-based national programs targeted at better preventing and
managing diabetes and hypertension.
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Data monitoring
Because this study does not involve any testing of medi-
cations or procedures that are outside the usual care
provided to individuals with type 2 diabetes, monitoring
patient safety will be limited to mandatory reporting of
adverse events and unanticipated problems. Participants
will be made aware of unexpected test findings identified
during the trial. Adverse events include clinical reactions
to blood draws related to the study, as well as any
reported stigma or physical or mental harm as a result
of participation in the study, including disclosure of
diabetes status.
Foreseeable risks, discomforts, and inconvenience to
participants
Trial participation is voluntary, so that participants may
leave the trial at any time for whatever reason. Because
the provision of education should only add to the partic-
ipants’ knowledge about how to manage their diabetes,
we see no immediate risks for participants. This add-
itional information may lead to an increased awareness
of the risks of sustained high glucose levels and could in-
crease anxiety in participants. Theoretically, the personal
experience or beliefs of the peer educators may lead
them to diverge from the educational material to pro-
mote potentially harmful or ineffective practices for
treating diabetes.
Provisions in place to minimize risk
The possible high returns from participating in the peer
education sessions and from knowing their HbA1c and
other biomarkers will be emphasized to motivate pa-
tients to continue trial participation. Because the control
and intervention groups will receive their blood test re-
sults, any effects on our outcome variables due to receiv-
ing this information should not affect the estimate of the
intervention effect. To prevent peer educators from pro-
moting ineffective and potentially harmful treatments of
diabetes, we will carefully select peer educators and
emphasize the need to follow the content of the educa-
tion materials during the peer education sessions. We
may also aim to address some myths surrounding
diabetes and how diabetes should be treated to increase
awareness of the potential dangers of ineffective treat-
ments, which peer educators can use to address such
beliefs in their peer education sessions.
Discussion
The goal of this cluster randomized controlled trial is to
test the effectiveness of peer education to improve dia-
betes-related outcomes in a low-income setting with a
high burden of diabetes.
This trial has several advantages over previous trials
carried out on peer education for diabetes in low- and
middle-income countries. First, its relatively long follow-
up allows us to observe the effectiveness of peer educa-
tion over a longer time. Second, because we measure not
only HbA1c but also blood lipids, we will be also able to
investigate the effects of peer education on these risk
factors for diabetes complications. Further, we collect in-
formation on risk and time preferences, which will allow
us to assess whether the effectiveness of the intervention
depends on such personal patient characteristics. Finally,
we will provide a first estimate of the cost-effectiveness
of peer education in a low-income context with the goal
of informing policy makers of the costs and benefits of
the intervention, and in comparison to other interven-
tions in the health sector.
If the trial shows that peer education is effective in im-
proving diabetes outcomes in Indonesia, the next step
will be to explore the potential for the intervention to be
integrated into the local health-care system, considering
the practicability of the intervention and its cost-effect-
iveness. We have been in contact with local health au-
thorities who are supporting the study and will
disseminate the results to them and other authorities
once the study has concluded.
Trial status
The current version of this protocol is 1.5, dated 5
August 2019. Enrollment began on 18 February 2019
and concluded on 10 April 2019.
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